Loading…
Privia Health Group, Inc. operates as a national physician-enablement company in the United States. The company collaborates with physician practices, health plans, and health systems. It also offers technology and population health tools to enhance providers' workflows; management services organization that enable providers to focus on their patients by reducing administrative work; and single-TIN medical group that facilitates negotiating power, clinical integration, and alignment of financial incentives. In addition, the company operates accountable care organization, which engages patients, reduce inappropriate utilization, and enhance coordination and patient quality metrics to drive value-based care; and network for purchasers and payers that enable providers to connect across platform to better understand the holistic needs of each patient and connect with other providers to address individual medical needs. The company was founded in 2007 and is headquartered in Arlington, Virginia.
5-year financial trends. Figures in USD millions.
Latest fiscal year: 2025
Year-by-year revenue, profitability, and cash flow (USD millions, last 10 years)
| Year | Revenue | EBITDA | Net Profit | FCF | ROE | Rev Growth 1Y | NP Growth 1Y |
|---|---|---|---|---|---|---|---|
| 2025 | $2.1B | $44M | $23M | $163M | 3.1% | 22.3% | 59.3% |
| 2024 | $1.7B | $24M | $14M | $109M | 2.3% | 4.7% | -37.7% |
| 2023 | $1.7B | $27M | $23M | $81M | 4.1% | 22.2% | -368.8% |
| 2022 | $1.4B | $-15M | $-9M | $47M | -1.7% | - | - |
| 2021 | - |
Income statement, balance sheet, and cash flow as reported
Consolidated Figures in USD Millions.
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total Revenue | - | 1,356.66 | 1,657.74 | 1,736.39 | 2,122.84 |
| Cost Of Revenue | - | 1,221.88 | 1,496.24 | 1,559.54 | 1,913.41 |
| Gross Profit | - | 134.78 | 161.50 | 176.85 | 209.43 |
| Operating Expense | - | 153.90 | 140.85 | 159.87 | 175.20 |
| Operating Income | - | -19.12 | 20.65 | 16.98 | 34.24 |
| EBITDA | - | -14.55 | 27.18 | 24.25 | 44.14 |
| EBIT | - | -19.12 | 20.65 | 16.98 | 34.24 |
| Pretax Income | - | -18.58 | 29.02 | 27.87 | 43.94 |
| Tax Provision | - | -6.52 | 7.99 | 10.83 | 14.21 |
| Net Income | - | -8.59 | 23.08 | 14.38 | 22.92 |
| Net Income Common Stockholders | - | -8.59 | 23.08 | 14.38 | 22.92 |
| Total Expenses | - | 1,375.78 | 1,637.09 | 1,719.41 | 2,088.61 |
| Interest Expense | 1.07 | - | - | - | - |
| Selling General And Administration | - | 149.33 | 134.32 | 152.60 | 165.29 |
| Normalized EBITDA | - | -14.55 | 27.18 | 24.25 | 44.14 |
| Normalized Income | - | -8.59 | 23.08 | 14.38 | 22.92 |
| Market Cap | 2,994.90 | 2,994.90 | 2,994.90 | 2,994.90 | 2,994.90 |
Healthcare sector peers, ranked by market cap
| Company | Ticker | Market Cap | P/E | P/B | ROE | EV/EBITDA |
|---|---|---|---|---|---|---|
| Privia Health Group, Inc.this co. | PRVA | $2.9B | 130.67↑ premium | 4.06 | 3.1% | 57.20 |
| Catalyst Pharmaceuticals, Inc. | CPRX | $3.4B | 15.60 | 3.50 | 22.5% | 8.92 |
| ICU Medical, Inc. | ICUI | $3.0B | 4261.68 | 1.47 | 0.0% | 13.89 |
| Integer Holdings Corporation | ITGR | $3.0B | 28.79 | 1.69 | 5.9% | 14.55 |
| Organon & Co. | OGN | $2.9B |
| - |
| - |
| - |
| - |
| - |
| - |
| 15.67 |
| 3.90 |
| 24.9% |
| 8.53 |
| Prestige Consumer Healthcare Inc. | PBH | $2.9B | 13.00 | 1.52 | 11.7% | 10.32 |
| Veracyte, Inc. | VCYT | $2.7B | 41.28 | 2.09 | 5.1% | 26.96 |
| National HealthCare Corporation | NHC | $2.7B | 22.47 | 2.52 | 11.2% | 12.59 |
| LeMaitre Vascular, Inc. | LMAT | $2.6B | 44.90 | 6.59 | 14.7% | 30.28 |
| Peer Median | - | 25.63 | 2.31 | 11.5% | 13.24 | |